1- Mion F pour Société Nationale Française de GastroEntérologie, Groupe Français de Neuro-Gastroentérologie. Prise en charge de la dyspepsie. Fév 2014. Disponible sur www.snfge.org/content/cp013-prise-en-charge-de-la-dyspepsie
2- Talley NJ et al. Guidelines for the management of dyspepsia. Am J Gastroenterol 2005; 100: 2324-37
3- Zagari RM, Fuccio L, Bazzoli F. Investigating dyspepsia. BMJ. 2008 Sep 15;337
4- Veldhuyzen van Zanten SJO, Chiba N, Armstrong D et al. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: The CADET-HN Study. Am J Gastroenterol 2005;100:1477-88
5- INAMI. L’usage adéquat des inhibiteurs d’acide dans le reflux gastro-œsophagien et la dyspepsie. Réunion de consensus 15 mai 2003. Disponible sur http://www.facm.ucl.ac.be/cours/Van-Bambeke/FARM22/2004-2005/guidelines…
6- Jian R. Dyspepsie : explorer ou traiter ? Cours pour le DES de Gastro-entérologie. 2010. Disponible sur http://hepatoweb.com/DES/exposes/DES_16012010_COFFIN/JIAN.pdf
7- Richard-Molard M. Dyspepsie chronique idiopathique. Séminaire de Tursac. Octobre 2006. Disponible sur http://hepatoweb.com/DES/DES_GO/SEMINAIRE_102006/DYSPEPSIE.pdf
8- Ford AC, Qume M, Moayyedi P, Arents NL, Lassen AT, Logan RF, McColl KE, Myres P, Delaney BC. Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis. Gastroenterology. 2005 Jun;128(7):1838-44
9- Lassen AT et al. Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial. Gut 2004;53:1758-1763
10- Vakil N, Talley N, van Zanten SV, Flook N, Persson T, Björck E, Lind T, Bolling-Sternevald E; STARS I Study Group. Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms. Clin Gastroenterol Hepatol. 2009 Jul;7(7):756-61
11- Holtmann G, Talley NJ, Liebregts T et al. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006 ; 354 : 832-40
12- Mc Coll Ket al.Symptomatic benefit from eradicating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med 1998;339:1869-74.
13- Blum AL et al. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med 1998 ;339:1875-81.
14- Calvert EL, Houghton LA, Cooper P, Morris J, Whorwell PJ. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology. 2002 Dec;123(6):1778-85
15- Malfertheiner P, Megraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection – The Maastricht III Consensus Report. Gut 2007
16- Humair JP, Iliescu I. Dyspepsie. 2009. Disponible sur www.hug-ge.ch/sites/interhug/files/atelier_mpr/090204_Dyspepsie.ppt
17- Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006 Apr;130(5):1377-90
18- Moayyedi P, Soo S, Deeks JJ et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002096
19- Hôpitaux universitaires de Genève. Dyspepsie. 2010. Disponible sur http://www.hug-ge.ch/sites/interhug/files/structures/medecine_de_premie…
20- Bytzer P. Dyspepsia as an adverse effect of drugs. Best Pract Res Clin Gastroenterol 2010;24:109-20
21- Von Marrewijk CJ, Mujakovic S, Fransen GA, et al. Effect and costeffectiveness of step-up versus stepdown treatment with antacids, H2 receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial. Lancet 2009;373:215-25
22- Bruley des Varannes S. Prise en charge de la dyspepsie fonctionnelle. Journées Francophones d’Hépato-gastroentérologie et d’Oncologie Digestive 2011 . Disponible sur http://www.fmcgastro.org/wp-content/uploads/file/ppt-2011/305_Stanislas…
23- Chiba N, Veldhuyzen van Zanten SJ, Sinclair P et al. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: The Canadian Adult Dyspepsia Empiric Treatment - H pylori (CADET-Hp) randomised controlled trial. BMJ 2002;324:1012-6
24-Moayyedi P, Shelly S, Deeks JJ, Delaney B, Innes M, Forman D. WITHDRAWN:Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD001960
25- Harvey RF, Lane JA, Nair P, et al. Clinical trial: prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations - the Bristol Helicobacter Project. Aliment Pharmacol Ther 2010;32:394-400
26- Ford AC, Forman D, Bailey AG, et al. A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial. Gastroenterology 2005;129:1910-7.
27- Bazzoli F. Key points from the revised Maastricht Consensus Report: the impact on general practice. Eur J Gastroenterol Hepatol. 2001 Aug;13 Suppl 2:S3-7
28- Mertz H, Fass R, Kodner A, et al. Effect of amitryptiline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998;93:160-5
Mise au point
Prise en charge de la goutte en 2025
Mise au point
Le prurit
Mise au point
Les infiltrations en médecine générale
Mise au point
Diagnostic de la maladie d’Alzheimer en 2025